Endostatin in Concurrent Chemoradiotherapy of head and neck cancer: A Randomized Controlled Prospective Study
Phase of Trial: Phase II
Latest Information Update: 24 Jul 2014
At a glance
- Drugs Endostatin (Primary) ; Antineoplastics
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Planned initiation date (1 Jan 2009) added as reported by Chinese Clinical Trial Register record.
- 21 May 2012 Planned End Date (31 Jan 2019) added as reported by Chinese Clinical Trial Register record.
- 05 Dec 2011 New trial record